Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06518850
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-13
Brief Title:
Study of Clinical Features and Efficacy of Small Intestinal Bacterial Overgrowth in Patients With Abdominal Distension
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multicentre Study of Clinical Features and Efficacy of Small Intestinal Bacterial Overgrowth in Abdominal Distension Patients
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Most studies of bloating have focused on functional factors while data on organic abdominal distention are rare and studies that combine small intestine bacterial overgrowth andor oral cecum transit time abnormalities are more urgent to explore On this basis patients with functional abdominal distension complicated with small intestine bacterial overgrowth were divided according to whether there was abnormal oral cecum transit time and given the same treatment plan The relief effect of abdominal distension small intestine bacterial overgrowth turning negative and oral cecum transit time recovery were observed so as to further clarify the cause of abdominal distension patients
Detailed Description:
Part 1 Clinical characteristics of small intestinal bacterial overgrowth in patients with abdominal distension of different etiologies The clinical characteristics of small intestine bacterial overgrowth and oral cecum transit time in patients with abdominal distention of different etiology organic and functional were studied to lay a foundation for further exploration of treatment of functional abdominal distention
Part 2 Efficacy observation of functional abdominal distention combined with small intestine bacterial overgrowth To observe the effect of antibiotics on abdominal distension in patients with functional abdominal distension complicated with small intestine bacterial overgrowth and observe the effect of rifaximin on small intestine bacterial overgrowth and oral cecum transit time so as to provide new ideas for the diagnosis and treatment of abdominal distension patients
Part 2 Efficacy observation of functional abdominal distention combined with small intestine bacterial overgrowth To observe the effect of antibiotics on abdominal distension in patients with functional abdominal distension complicated with small intestine bacterial overgrowth and observe the effect of rifaximin on small intestine bacterial overgrowth and oral cecum transit time so as to provide new ideas for the diagnosis and treatment of abdominal distension patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None